Scholarlink

Background <p><i>Blastocystis hominis</i> infection in patients with Parkinson’s disease may exacerbate gut microbiota dysbiosis, potentially worsening neurological symptoms; however, such associations remain speculative without microbiome data. Targeted interventions to restore gut microbial balance could mitigate disease progression and improve patient outcomes.</p> Case presentation <p>An 86-year-old Caucasian male presented to the emergency department with severe watery diarrhea, up to six episodes per day, of 1&#xa0;month duration. The patient’s diarrhea was nonbloody and nonmucoid. He denied fever, nausea, vomiting, abdominal pain, bloating, loss of appetite, or anal itching. There was no history of weight loss, fatigue, or systemic symptoms.</p> <p>A stool sample was examined microscopically using normal saline, revealing <i>Blastocystis hominis</i> cysts (the burden was not quantified) and a rare white blood cell count. The sample was concentrated using acetylacetate and ether. Additional tests, including <i>Clostridioides difficile</i> and other common infectious pathogens, were ruled out in our patient to address alternative infectious etiologies.The patient was started on intravenous ciprofloxacin and metronidazole, resulting in an improvement in diarrhea consistency and frequency until the resolution of symptoms within 4&#xa0;days of initiating intravenous therapy. The patient also reported mild improvement in his Parkinson’s disease symptoms by the end of hospitalization, though objective neurologic post-treatment scoring (eg. Unified Parkinson’s Disease Rating Scale) was not performed.</p> Conclusion <p>This case highlights the need to consider parasitic infections in patients with Parkinson’s disease presenting with chronic diarrhea. While we hypothesize that <i>B. hominis</i> infection may transiently worsen Parkinson’s disease symptoms through inflammatory or microbiota-mediated pathways, this remains speculative in the absence of microbiome sequencing or objective neurologic evaluation. Further studies integrating clinical, microbiological, and microbiome analyses are warranted.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Blastocystis hominis infection inducing gut microbiome dysbiosis and aggravating Parkinson’s disease symptoms: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月16日

查看全文
  • Emanuel-Youssef Dib,
  • Philippe Attieh,
  • Karam Karam,
  • Lama Al Akel,
  • Loulewa Al Sayed,
  • Tala Charafeddine,
  • Laila Al Akel,
  • Serena Khoury,
  • Walid Abdel Khalek

摘要

Background

Blastocystis hominis infection in patients with Parkinson’s disease may exacerbate gut microbiota dysbiosis, potentially worsening neurological symptoms; however, such associations remain speculative without microbiome data. Targeted interventions to restore gut microbial balance could mitigate disease progression and improve patient outcomes.

Case presentation

An 86-year-old Caucasian male presented to the emergency department with severe watery diarrhea, up to six episodes per day, of 1 month duration. The patient’s diarrhea was nonbloody and nonmucoid. He denied fever, nausea, vomiting, abdominal pain, bloating, loss of appetite, or anal itching. There was no history of weight loss, fatigue, or systemic symptoms.

A stool sample was examined microscopically using normal saline, revealing Blastocystis hominis cysts (the burden was not quantified) and a rare white blood cell count. The sample was concentrated using acetylacetate and ether. Additional tests, including Clostridioides difficile and other common infectious pathogens, were ruled out in our patient to address alternative infectious etiologies.The patient was started on intravenous ciprofloxacin and metronidazole, resulting in an improvement in diarrhea consistency and frequency until the resolution of symptoms within 4 days of initiating intravenous therapy. The patient also reported mild improvement in his Parkinson’s disease symptoms by the end of hospitalization, though objective neurologic post-treatment scoring (eg. Unified Parkinson’s Disease Rating Scale) was not performed.

Conclusion

This case highlights the need to consider parasitic infections in patients with Parkinson’s disease presenting with chronic diarrhea. While we hypothesize that B. hominis infection may transiently worsen Parkinson’s disease symptoms through inflammatory or microbiota-mediated pathways, this remains speculative in the absence of microbiome sequencing or objective neurologic evaluation. Further studies integrating clinical, microbiological, and microbiome analyses are warranted.